Proteostasis shares zoom north as their cystic fibrosis doublet causes a stir in small study -- triggering an online brawl
Sometimes it’s the smallest studies that gain the biggest reactions from the investment crowd that follows biotech.
Case in point: Little Proteostasis Therapeutics hit big …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
